TIPPing practice away from anticoagulation in pregnancy

The Lancet

Volumn 384, Issue 9955, 2014, Pages 1648-1649

  Gibson, Paul S ^a   Nerenberg, Kara A ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANESTHETIC AGENT; ANTICOAGULANT AGENT; DALTEPARIN; LOW MOLECULAR WEIGHT HEPARIN; FIBRINOLYTIC AGENT;

ANTICOAGULANT THERAPY; CLINICAL PRACTICE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EPIDEMIOLOGICAL DATA; EVIDENCE BASED MEDICINE; FETUS GROWTH; HEALTH CARE COST; HIGH RISK PATIENT; HUMAN; LABOR INDUCTION; NOTE; PRACTICE GUIDELINE; PREECLAMPSIA; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIORITY JOURNAL; REGIONAL ANESTHESIA; RISK REDUCTION; SMALL FOR DATE INFANT; STILLBIRTH; THROMBOPHILIA; VENOUS THROMBOEMBOLISM; COMPLICATION; FEMALE; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR;

DALTEPARIN; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; THROMBOPHILIA;

EID: 84920923189     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(14)60850-3     Document Type: Note

References (13)

1. MJ Kupferminc, A Eldor, N Steinman et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy N Engl J Med 340 1999 9 13
2. E Rey, SR Kahn, M David, I Shrier Thrombophilic disorders and fetal loss: a meta-analysis Lancet 361 2003 901 908
3. JC Gris, E Mercier, I Quéré et al. Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder Blood 103 2004 3695 3699
4. B Brenner, R Hoffman, H Carp, M Dulitsky, J Younis Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study J Thromb Haemost 3 2005 227 229
5. SM Bates, IA Greer, J Hirsh, JS Ginsberg Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 2004 627S 644S
6. JIP de Vries, MG van Pampus, WM Hague, PD Bezemer, JH Joosten Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT J Thromb Haemost 10 2012 64 72
7. I Martinelli, P Ruggenenti, I Cetin et al. Heparin in pregnant women with previous placenta-mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial Blood 119 2012 3269 3275
8. MA Rodger, WM Hague, J Kingdom et al. Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial Lancet 2014 published online July 25. http://dx.doi.org/10.1016/S0140-6736(14)60793-5
9. MA Rodger, MT Betancourt, P Clark et al. The association of factor V Leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studies PLoS Med 7 2010 e1000292
10. SP Kaandorp, M Goddijn, JA van der Post et al. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage N Engl J Med 362 2010 1586 1596
11. P Clark, ID Walker, P Langhorne on behalf of the Scottish Pregnancy Intervention Study (SPIN) collaborators SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage Blood 115 2010 4162 4167
12. LM Askie, L Duley, DJ Henderson-Smart, LA Stewart Antiplatelet agents for prevention of preeclampsia: a meta-analysis of individual patient data Lancet 369 2007 1791 1798
13. SM Bates, IA Greer, S Middeldorp, DL Veenstra, AM Prabulos, PO Vandvik VTE, thrombophilia, antithrombotic therapy, and pregnancy. Antithrombotic Therapy and Prevention of Thrombosis, 9th edn: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2 suppl 2012 e691S e736S